Table 2. Analysis of Cholesterol in SCD and Healthy Patients.
| Patient B cell | SCD status | TC (nmol/mg pr.)a | UC (nmol/mg pr.)b | CE (nmol/mg pr.)c | Ester/Total (%) | ||||||||
| line ID | AVE | ± | SD | AVE | ± | SD | AVE | ± | SD | AVE | ± | SD | |
| 66K00597 | unaffected control | 44.0 | ± | 8.1 | 44.5 | ± | 8.7 | −0.6 | ± | 2.2 | −1.2 | ± | 4.5 |
| BUC692RDP692A | |||||||||||||
| 66K00594 | unaffected control | 51.7 | ± | 8.4 | 49.9 | ± | 8.6 | 1.8 | ± | 0.2 | 3.5 | ± | 0.9 |
| BUC704RDP704A | |||||||||||||
| 66K00595 | unaffected control | 57.5 | ± | 0.3 | 55.1 | ± | 0.8 | 2.4 | ± | 1.0 | 4.2 | ± | 1.8 |
| BUC708RDP708A | |||||||||||||
| 64101374 | affected proband | 44.1 | ± | 0.7 | 42.2 | ± | 1.3 | 1.8 | ± | 0.6 | 4.2 | ± | 1.4 |
| SCD Family AA | |||||||||||||
| 64101375 | unaffected sibling | 46.9 | ± | 2.3 | 45.9 | ± | 2.2 | 1.0 | ± | 0.2 | 2.2 | ± | 0.4 |
| SCD Family AA | |||||||||||||
| 64101376 | affected proband | 51.1 | ± | 1.5 | 49.6 | ± | 1.2 | 1.5 | ± | 0.3 | 3.0 | ± | 0.5 |
| SCD Family GG | |||||||||||||
a
TC: total cholesterol.
b
UC: unesterified cholesterol.
c
CE: cholesteryl ester.